With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Abstract: In smoke interference scenarios, visible image degradation significantly limits the availability of detailed information for fusion. Moreover, a single fusion network often struggles to ...
Over the past decade, RNA interference (RNAi) technology has matured into a clinically validated therapeutic approach, with multiple small interfering RNA (siRNA) drugs delivering durable gene ...
Abstract: Code hopping multiple access (CHMA) is an emerging technology to implement code domain non-orthogonal multiple access (NOMA). In CHMA, multiple access interference and multipath interference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results